1. Home
  2. LIDR vs AYTU Comparison

LIDR vs AYTU Comparison

Compare LIDR & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • AYTU
  • Stock Information
  • Founded
  • LIDR 2013
  • AYTU N/A
  • Country
  • LIDR United States
  • AYTU United States
  • Employees
  • LIDR N/A
  • AYTU N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIDR Consumer Discretionary
  • AYTU Health Care
  • Exchange
  • LIDR Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • LIDR 9.8M
  • AYTU 10.5M
  • IPO Year
  • LIDR N/A
  • AYTU N/A
  • Fundamental
  • Price
  • LIDR $1.16
  • AYTU $1.72
  • Analyst Decision
  • LIDR Hold
  • AYTU
  • Analyst Count
  • LIDR 1
  • AYTU 0
  • Target Price
  • LIDR N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • LIDR 7.9M
  • AYTU 27.8K
  • Earning Date
  • LIDR 11-12-2024
  • AYTU 02-12-2025
  • Dividend Yield
  • LIDR N/A
  • AYTU N/A
  • EPS Growth
  • LIDR N/A
  • AYTU N/A
  • EPS
  • LIDR N/A
  • AYTU N/A
  • Revenue
  • LIDR $225,000.00
  • AYTU $79,759,000.00
  • Revenue This Year
  • LIDR N/A
  • AYTU N/A
  • Revenue Next Year
  • LIDR $2,650.00
  • AYTU N/A
  • P/E Ratio
  • LIDR N/A
  • AYTU N/A
  • Revenue Growth
  • LIDR N/A
  • AYTU N/A
  • 52 Week Low
  • LIDR $0.78
  • AYTU $1.30
  • 52 Week High
  • LIDR $5.15
  • AYTU $3.45
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 44.91
  • AYTU 54.14
  • Support Level
  • LIDR $1.15
  • AYTU $1.60
  • Resistance Level
  • LIDR $4.30
  • AYTU $1.93
  • Average True Range (ATR)
  • LIDR 0.58
  • AYTU 0.13
  • MACD
  • LIDR -0.10
  • AYTU 0.01
  • Stochastic Oscillator
  • LIDR 0.95
  • AYTU 57.00

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: